US Supreme Court Allows Continued Mail-Order Shipment of Abortion Pills
The US Supreme Court has issued an emergency order allowing the continued prescription and mail-order shipment of abortion pills, specifically mifepristone, across the United States. This decision stays a lower appeals court ruling that had blocked a 2023 Food and Drug Administration (FDA) regulation facilitating telemedicine access to the drug. The high court approved urgent applications from pharmaceutical manufacturers Danco Laboratories and GenBioPro, with conservative Justices Samuel Alito and Clarence Thomas dissenting. The legal challenge was initiated by Louisiana, which argued the FDA rule ignored health risks, but the Trump administration opposed the state's lawsuit, citing lack of standing and ongoing safety reviews. This ruling is significant as abortion rights remain a central issue ahead of the November congressional elections. Since the Supreme Court overturned the nationwide right to abortion in 2022, medical abortions have risen to account for approximately two-thirds of all procedures in the country. The FDA and experts continue to classify mifepristone, approved since 2000, as safe and effective.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection